Current Ratio of X4 Pharmaceuticals, Inc from 30 Sep 2018 to 30 Sep 2025

Taxonomy & unit: ratio: %
Description: The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary: X4 Pharmaceuticals, Inc quarterly Current Ratio in % history and change rate from 30 Sep 2018 to 30 Sep 2025.
X4 Pharmaceuticals, Inc Current Ratio for the quarter ending 30 Sep 2025 was 393%, a 22% decline year-over-year.

Current Ratio, Quarterly (%)

Current Ratio, YoY Quarterly Change (%)

X4 Pharmaceuticals, Inc Quarterly Current Ratio (%)

Period	Value	YoY Chg	Change %	Date
Q3 2025	393%	-111%	-22%	30 Sep 2025
Q2 2025	382%	-147%	-28%	30 Jun 2025
Q1 2025	450%	-87%	-16%	31 Mar 2025
Q4 2024	452%	-121%	-21%	31 Dec 2024
Q3 2024	505%	-79%	-14%	30 Sep 2024
Q2 2024	529%	+33%	+6.6%	30 Jun 2024
Q1 2024	537%	+142%	+36%	31 Mar 2024
Q4 2023	573%	+189%	+49%	31 Dec 2023
Q3 2023	584%	+211%	+57%	30 Sep 2023
Q2 2023	496%	+41%	+9.1%	30 Jun 2023
Q1 2023	395%	-221%	-36%	31 Mar 2023
Q4 2022	384%	-324%	-46%	31 Dec 2022
Q3 2022	373%	-355%	-49%	30 Sep 2022
Q2 2022	455%	-298%	-40%	30 Jun 2022
Q1 2022	616%	-189%	-23%	31 Mar 2022
Q4 2021	708%	-224%	-24%	31 Dec 2021
Q3 2021	727%	-373%	-34%	30 Sep 2021
Q2 2021	753%	-455%	-38%	30 Jun 2021
Q1 2021	805%	-294%	-27%	31 Mar 2021
Q4 2020	933%	+233%	+33%	31 Dec 2020
Q3 2020	1100%	+639%	+139%	30 Sep 2020
Q2 2020	1208%	+826%	+216%	30 Jun 2020
Q1 2020	1098%	+783%	+248%	31 Mar 2020
Q4 2019	699%	+205%	+41%	31 Dec 2019
Q3 2019	461%	-178%	-28%	30 Sep 2019
Q2 2019	382%			30 Jun 2019
Q1 2019	316%			31 Mar 2019
Q4 2018	494%			31 Dec 2018
Q3 2018	639%			30 Sep 2018

* An asterisk sign (*) next to the value indicates that the value is likely invalid.